Korro Bio (KRRO) Return on Equity [ROE] (2019 - 2026)
Korro Bio (KRRO) reported Return on Equity [ROE] of -95.71% for Q2 2026, down 23.79 percentage points from -71.92% a year earlier but up 36.98 percentage points from the prior quarter.
Korro Bio (KRRO) Return on Equity [ROE] (2019 - 2026) Analysis & Trends
For FY2025, Korro Bio posted Return on Equity [ROE] of -110.70%, down 60.09 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -95.96 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -50.61% in FY2024 (+178.44 pp), -229.04% in FY2023 and -112.70% in FY2021 (-97.97 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -974.80% in Q4 2023 and a high of -46.50% in Q3 2024.
- Year over year, Return on Equity [ROE] has now declined in each of the last six quarters, with an average year-over-year change of +93.40 percentage points over the last seven quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 925.65 percentage points); the low point was Q1 2022 (a drop of 226.23 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -132.69% (Q1 2026), -155.86% (Q4 2025) and -82.58% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Korro Bio | 141.76 Mn | -254.88 Mn | - | -95.71% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -95.71% |
| Mar 31, 2026 | -132.69% |
| Dec 31, 2025 | -155.86% |
| Sep 30, 2025 | -82.58% |
| Jun 30, 2025 | -71.92% |
| Mar 31, 2025 | -58.40% |
| Dec 31, 2024 | -49.16% |
| Sep 30, 2024 | -46.50% |
| Jun 30, 2024 | -48.82% |
| Mar 31, 2024 | -50.50% |
| Dec 31, 2023 | -974.80% |
| Sep 30, 2022 | -96.41% |
| Jun 30, 2022 | -87.59% |
| Mar 31, 2022 | -248.92% |
| Dec 31, 2021 | -161.45% |
| Sep 30, 2021 | -46.89% |
| Jun 30, 2021 | -31.22% |
| Mar 31, 2021 | -22.69% |
| Dec 31, 2020 | -13.52% |
| Sep 30, 2020 | -12.05% |
Korro Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KRRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();